Research Article

Antimicrobial Susceptibility Profiles and Prevalence of ESBLS among Escherichia coli Isolates Recovered from Clinical Specimens in Different Services

Volume: 5 Number: 3 December 31, 2019
Tuğba Cebeci *, Dilek Keskin , Ahmet Ali Gökal
EN

Antimicrobial Susceptibility Profiles and Prevalence of ESBLS among Escherichia coli Isolates Recovered from Clinical Specimens in Different Services

Abstract

Objective: A retrospective analysis of the widely used antibiotics all susceptibility testing results from Escherichia coli cultured from clinical specimens private hospital from (January 2016 to November 2018) was performed.

Methods: The VITEK 2 Compact automated microbiology system is designed for automated rapid antimicrobial susceptibility testing and identification of clinically relevant bacteria. Minimum inhibitory concentration (MIC) results previously obtained in recent clinical isolates with well-defined in isolates with well-characterized resistance mechanisms with the microdilution method were re-interpreted for the susceptible, intermediate and resistant categories using the 2018 EUCAST breakpoints. Clinical samples are most commonly isolated from blood, sputum and urine samples.

Results: Escherichia coli isolates were highly resistant to ampicillin, cefuroxime and cefixime 79,16%, 60,41% and 58,33% respectively. Resistance rate of ceftriaxon was showed in 52,08%. When we compared to resistance of trimethoprim/sulfamethoxazole, Escherichia coli isolates showed 51,04% resistance rate. When it comes to the most sensitive antibiotics, sensitivity rate of fosfomycin, nitrofurantoin, ertapenem, imipenem, meropenem, gentamicin, and amikacin were 89,58%; 91,66%; 93,75%; 93,75%; 94,79%; 83,33%; 84,37% respectively.

Conclusion: Considering the antibiogram, fosfomycin, nitrofurantoin, ertapenem, imipenem, meropenem, gentamicin and amikacin should be preferred drugs for E. coli infection isolated from clinical samples.

Keywords

E. coli,antibiotic sensitivity,clinical specimens

References

  1. Albayrak N, Kaya S. Extended spectrum beta lactamases production and antimicrobial resistance ratio of Escherichia coli and Klebsiella pneumoniae strains isolated from various clinical samples. Turk Mikrobiyol Cem Derg. 2009; 39(1-2):16-21.
  2. Al-salamy AK. Detection of extended spectrum-beta lactamase enzymes producing E. coli that isolated from urine. Kufa Journal for Veterinary Medical Sciences 2012; 3(1):55-66.
  3. Ayatollahi J, Shahcheraghi SH, Akhondi R, Soluti S. Antibiotic Resistance Patterns of Escherichia coli Isolated from Children in Shahid Sadoughi Hospital of Yazd. Iran J Ped Hematol Oncol. 2013; 3(2):78–82.
  4. Ayub M, Amir JS, Firdous K. E. coli the Most Prevalent Causative Agent Urinary Tract Infection in Pregnancy: Comparative Analysis of Susceptibility and Resistance Pattern of Antimicrobials. Arch Clin Microbiol. 2016; 7:4. doi:10.4172/1989-8436.100054.
  5. Cappuccino JG, Sherman N. Microbiology: A Laboratory Manual. 7th Edn. Pearson Education (Singapore) 2004, Indian Branch, New Delhi, ISBN: 080532836X. pp: 544.
  6. Cheema, UK, Saleem S, Chaudary MA. Isolation and Antimicrobial Susceptibility Profile of Microorganisms Isolated from Ventilator Associated Pneumonia Patients. J Infec Dis Treat 2018; 4(1):3. doi:10.21767/2472-1093.100041
  7. Dash M, Padhi S, Mohanty I, Panda P, Parida B. Antimicrobial resistance in pathogens causing urinary tract infections in a rural community of Odisha, India J Family Community Med. 2013; 20(1):20-6.
  8. Devrim F, Serdaroğlu E, Çağlar İ, Oruç Y, Demiray N, Bayram N, et al. The emerging resistance in nosocomial urinary tract infections: From the pediatrics perspective. Mediterr J Hematol Infect Dis 2018; 10:1-5.
  9. Eryilmaz M, Bozkurt ME, Yildiz MM, Akın A. Investigation of the prevalance of extended spectrum beta lactamase producing Escherichia coli strains isolated from various clinical samples. Marmara Ecza Derg 2010; 14:10-12.
  10. Fajfr M, Louda M, Paterova P, Ryskova L, Pakovsky J, Kosina J. The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study. BMC Urol. 2017; 17:33.
APA
Cebeci, T., Keskin, D., & Gökal, A. A. (2019). Antimicrobial Susceptibility Profiles and Prevalence of ESBLS among Escherichia coli Isolates Recovered from Clinical Specimens in Different Services. Middle Black Sea Journal of Health Science, 5(3), 186-191. https://doi.org/10.19127/mbsjohs.570826
AMA
1.Cebeci T, Keskin D, Gökal AA. Antimicrobial Susceptibility Profiles and Prevalence of ESBLS among Escherichia coli Isolates Recovered from Clinical Specimens in Different Services. Mid Blac Sea J Health Sci. 2019;5(3):186-191. doi:10.19127/mbsjohs.570826
Chicago
Cebeci, Tuğba, Dilek Keskin, and Ahmet Ali Gökal. 2019. “Antimicrobial Susceptibility Profiles and Prevalence of ESBLS Among Escherichia Coli Isolates Recovered from Clinical Specimens in Different Services”. Middle Black Sea Journal of Health Science 5 (3): 186-91. https://doi.org/10.19127/mbsjohs.570826.
EndNote
Cebeci T, Keskin D, Gökal AA (December 1, 2019) Antimicrobial Susceptibility Profiles and Prevalence of ESBLS among Escherichia coli Isolates Recovered from Clinical Specimens in Different Services. Middle Black Sea Journal of Health Science 5 3 186–191.
IEEE
[1]T. Cebeci, D. Keskin, and A. A. Gökal, “Antimicrobial Susceptibility Profiles and Prevalence of ESBLS among Escherichia coli Isolates Recovered from Clinical Specimens in Different Services”, Mid Blac Sea J Health Sci, vol. 5, no. 3, pp. 186–191, Dec. 2019, doi: 10.19127/mbsjohs.570826.
ISNAD
Cebeci, Tuğba - Keskin, Dilek - Gökal, Ahmet Ali. “Antimicrobial Susceptibility Profiles and Prevalence of ESBLS Among Escherichia Coli Isolates Recovered from Clinical Specimens in Different Services”. Middle Black Sea Journal of Health Science 5/3 (December 1, 2019): 186-191. https://doi.org/10.19127/mbsjohs.570826.
JAMA
1.Cebeci T, Keskin D, Gökal AA. Antimicrobial Susceptibility Profiles and Prevalence of ESBLS among Escherichia coli Isolates Recovered from Clinical Specimens in Different Services. Mid Blac Sea J Health Sci. 2019;5:186–191.
MLA
Cebeci, Tuğba, et al. “Antimicrobial Susceptibility Profiles and Prevalence of ESBLS Among Escherichia Coli Isolates Recovered from Clinical Specimens in Different Services”. Middle Black Sea Journal of Health Science, vol. 5, no. 3, Dec. 2019, pp. 186-91, doi:10.19127/mbsjohs.570826.
Vancouver
1.Tuğba Cebeci, Dilek Keskin, Ahmet Ali Gökal. Antimicrobial Susceptibility Profiles and Prevalence of ESBLS among Escherichia coli Isolates Recovered from Clinical Specimens in Different Services. Mid Blac Sea J Health Sci. 2019 Dec. 1;5(3):186-91. doi:10.19127/mbsjohs.570826